- Trials with a EudraCT protocol (104)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
104 result(s) found for: Immune Complex.
Displaying page 1 of 6.
EudraCT Number: 2010-024510-57 | Sponsor Protocol Number: TRIANT-TE | Start Date*: 2011-03-14 | |||||||||||
Sponsor Name:Fundació Lluita contra la SIDA | |||||||||||||
Full Title: Estudio Randomizado, Prospectivo, Controlado, para Comparar la Eficacia y Seguridad de Dos Estrategias Farmacológicas Diferentes sobre la Alteración Neurocognitiva en la Infección por VIH. Estudio ... | |||||||||||||
Medical condition: Alteración neurocognitiva en la infección por VIH. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003741-29 | Sponsor Protocol Number: MARAND-X | Start Date*: 2017-04-05 | ||||||||||||||||
Sponsor Name:A.S.L. TO 2 | ||||||||||||||||||
Full Title: MARAND-X Study: MARaviroc-based Treatment Switch in HIV-positive Patients with HAND: Consequences of Reducing Antiretroviral-associated NeurotoXicity | ||||||||||||||||||
Medical condition: HIV-infection, HIV-associated neurocognitive disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004892-36 | Sponsor Protocol Number: SLE subcuvia 04 Sep 2006 | Start Date*: 2007-03-15 | |||||||||||
Sponsor Name:Department of Rheumatology,University hospital,Lund | |||||||||||||
Full Title: An open randomized and comparative study on the efficacy and safety of additional treatment of subcutaneous immunoglobulin (Subcuvia) during cessation of Prednisolon in patients with active systemi... | |||||||||||||
Medical condition: Systemic Lupus Erythematosus (SLE) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002805-13 | Sponsor Protocol Number: LTF-304 | Start Date*: 2015-11-27 | |||||||||||
Sponsor Name:bluebird bio, Inc | |||||||||||||
Full Title: Longterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product | |||||||||||||
Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004457-40 | Sponsor Protocol Number: SL0023 | Start Date*: 2016-09-19 | |||||||||||
Sponsor Name:UCB Biopharma SPRL | |||||||||||||
Full Title: A MULTI-CENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY FOLLOWED BY AN OBSERVATIONAL PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL IN SU... | |||||||||||||
Medical condition: SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) RO (Completed) HU (Completed) BG (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006738-33 | Sponsor Protocol Number: CL-1205 | Start Date*: 2008-03-14 | |||||||||||
Sponsor Name:NatImmune A/S | |||||||||||||
Full Title: bLAC - A phase II double-blind, placebo controlled, clinical proof of concept trial of the efficacy of 8 weeks treatment of cutaneous warts with bLAC in immune suppressed, kidney transplanted patients | |||||||||||||
Medical condition: Cutaneous wart lesions on hands and/or feet at immune suppressed, kidney transplanted patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003525-42 | Sponsor Protocol Number: ACH471-201 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Achillion Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2a Proof-of-Mechanism, Open-Label Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients with Low C3 Levels Due to Either C3 Glomerulopathy (C3G) or Immune-Complex Membranopr... | |||||||||||||
Medical condition: biopsy-confirmed C3 Glomerulopathy (C3G) or idiopathic Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) and a low serum C3 level | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005459-18 | Sponsor Protocol Number: SP122PM2201 | Start Date*: 2015-09-10 | |||||||||||
Sponsor Name:SMARTPRACTICE | |||||||||||||
Full Title: Clinical Evaluation of Metal Panel Allergens Mercury, Aluminum and Palladium Dose Response Study | |||||||||||||
Medical condition: Diagnosis of Allergic Contact Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006016-33 | Sponsor Protocol Number: E410/2007 | Start Date*: 2008-09-30 |
Sponsor Name:Uniklinikum Tuebingen | ||
Full Title: Multicenter Phase II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts after a reduced intensity conditioning regimen for adult patients with acute leukemia | ||
Medical condition: Patients with acute leukemia with an indication for allogeneic HCT but without a suitable HLA-identical donor | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-000263-14 | Sponsor Protocol Number: PS017-15 | Start Date*: 2015-04-27 |
Sponsor Name:Walton Centre NHS Foundation Trust | ||
Full Title: Mycophenolate Treatment for Longstanding Complex Regional Pain Syndrome (MYPS I) | ||
Medical condition: Complex Regional Pain Syndrome (CRPS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003884-12 | Sponsor Protocol Number: EXTRAStudy | Start Date*: 2015-12-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII | |||||||||||||
Full Title: A pilot, prospective, randomized, open-label, blinded endpoint (PROBE) histopathology trial to assess the effects of ACE- inhibition therapy on glomerular proliferative lesions in patients with ext... | |||||||||||||
Medical condition: Extracapillary glomerulonephritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003902-14 | Sponsor Protocol Number: 16-118 | Start Date*: 2017-07-06 |
Sponsor Name:RWTH Aachen University, represented by the Clinical Trial Center (CTC-A) | ||
Full Title: Intravenous Fish Oil based Lipid Emulsion as Pharmaconutrient Strategy in High-Risk Cardiac Surgery Patients: a Phase II Dosing Study | ||
Medical condition: Given the recently meta-analyzed data from previous RCTs about fish oil , we hypothesize that the provision of intravenous (i.v.) FO (0.20 g/kg and 0.50 g/kg) to cardiac surgery patients may reduc... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005390-36 | Sponsor Protocol Number: UoL001109 | Start Date*: 2016-02-17 | |||||||||||
Sponsor Name:The University of Liverpool | |||||||||||||
Full Title: Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab (IFX) verses alpha interferon (aIFN), with genotyping and metabolomic profiling, towards a str... | |||||||||||||
Medical condition: Behcets Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020113-85 | Sponsor Protocol Number: CSLCT-BIO-l0-67 | Start Date*: 2011-09-20 | |||||||||||
Sponsor Name:CSL Behring GmbH | |||||||||||||
Full Title: A Multicentre, Interventional, Non-randomized, Open-label, Single-group Phase III Study to evaluate Plasma-Derived Antihaemophilic Factor/von Willebrand Factor Concentrate (Biostate®) for Immune To... | |||||||||||||
Medical condition: Male paediatric subjects with Haemophilia A who develped high titre antibodies to human coagulation Factor VIII | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) AT (Completed) GR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003031-35 | Sponsor Protocol Number: R04049 | Start Date*: 2015-11-20 | |||||||||||
Sponsor Name:Central Manchester University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: A Single Centre Study Investigating the Safety and Efficacy of an Immune Modulation Regimen in Mitigating the Alloimmune Response to Intravenous Laronidase in Infants With Severe Mucopolysaccharido... | |||||||||||||
Medical condition: Severe Mucopolysaccharidosis Type I (Hurler syndrome, MPS IH) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015242-30 | Sponsor Protocol Number: 2009-001 | Start Date*: 2009-11-05 |
Sponsor Name:The Walton Centre for Neurology and Neurosurgery NHS Trust | ||
Full Title: An open study to compare the efficacy of immunoglobulin administered subcutaneoulsy (SCIG) with current best practice in patients with Complex Regional Pain Syndrome (CRPS) | ||
Medical condition: Complex Regional Pain Syndrome (CRPS) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003767-25 | Sponsor Protocol Number: APL2-C3G-310 | Start Date*: 2022-03-08 | |||||||||||||||||||||
Sponsor Name:Apellis Pharmaceuticals, Inc. | |||||||||||||||||||||||
Full Title: A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune-Complex Membranoprolif... | |||||||||||||||||||||||
Medical condition: complement 3 glomerulopathy (C3G)/immune complex membranoproliferative glomerulonephritis (IC-MPGN) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) NL (Restarted) CZ (Completed) BE (Ongoing) AT (Ongoing) FR (Ongoing) PL (Completed) IT (Ongoing) ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003024-41 | Sponsor Protocol Number: 20190531 | Start Date*: 2023-01-25 | ||||||||||||||||
Sponsor Name:Amgen Inc | ||||||||||||||||||
Full Title: A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet’s Disease or 5 Years of Age or Older With Juv... | ||||||||||||||||||
Medical condition: Subjects with active Behçet's Disease or Juvenile Psoriatic Arthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) FR (Not Authorised) IT (Ongoing) GR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003028-30 | Sponsor Protocol Number: 808040019 | Start Date*: 2015-11-02 |
Sponsor Name:Technische Universität München, Fakultät für Medizin | ||
Full Title: Fr1da Insulin Intervention - Mechanistic study using oral insulin for immune and treatment efficacy in secondary prevention of type 1 diabetes | ||
Medical condition: Risk for type 1 diabetes | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005524-26 | Sponsor Protocol Number: GBI1406 | Start Date*: 2016-07-29 | |||||||||||
Sponsor Name:Grifols Biologicals Inc. | |||||||||||||
Full Title: A Multicenter Phase 2 Open-Label, Single-Arm, Prospective, Interventional Study of Plasma-Derived Factor VIIIIVWF Alphanate® in Immune Tolerance Induction Therapy in Subjects with Congenital Hemoph... | |||||||||||||
Medical condition: Inhibitors in patients with severe Congenital Haemophilia A | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: ES (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.